Orbicular's partner secures tentative U.S. ANDA approval for a generic version of Ozempic

OneSource is the contract development and manufacturing organization (CDMO) partner for this product

Lupin subsidiary settles US antitrust case with Humana for $30 Million

The litigation involved multiple civil lawsuits alleging anti-competitive practices and violations of federal

Pharma stocks face Q4 reality check amid global headwinds

Analysts expect modest revenue growth but pressure on profitability in the March quarter

Aurobindo Pharma bags USFDA nod for Glycerol Phenylbutyrate Oral Liquid

The approved product is a generic version of Ravicti, originally developed and marketed by Horizon Therapeutics

Loopworm’s silkworm-based ingredients found carbon negative in PwC-backed study

The study was conducted by PwC India in line with ISO 14040 and ISO 14044 protocols

C-CAMP hosts first National Diagnostics Conclave, unveils key reports and tools

Marking three years of the National Diagnostics Catapult (NDxC), the conclave launched the Impact Report and unveiled environmental surveillance kits

Eli Lilly flags counterfeit Mounjaro seizure in Gurugram

The company said it is supporting the ongoing investigation and reiterated its commitment to patient safety.

FDA pushes forward on gene-editing therapies with new safety roadmap

Genome editing holds extraordinary promise for treating previously incurable genetic diseases

Galderma rolls out next-generation regenerating skin nectar

Experts endorse low-sodium salt substitutes to cut India’s hypertension burden

Consensus calls for nationwide adoption of potassium-enriched salt to reduce cardiovascular disease risk